Skip to main content

Tissium - Biomorphic programmable polymers

Creating the future of tissue reconstruction

Learn more

A new era of reconstructive polymers

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures:

To reconstruct damaged tissue and restore its natural function.

Biomorphic programmable polymers

Our proprietary biomorphic programmable polymers enable tissue reconstruction and can be adapted for use in multiple clinical areas

Biomorphic

Conforms to and integrates with surrounding tissue to enable tissue reconstruction

Programmable

Polymer building blocks can be adjusted to match tissue-specific requirements

COAPTIUM® CONNECT

COAPTIUM® CONNECT is the first and only FDA-authorized system for atraumatic sutureless nerve coaptation.
Commercially available in The United States.

Learn more

Therapeutic areas

 

We design solutions for different tissue types for both open surgery and minimally invasive procedures

Peripheral Nerve

Cardiovascular

Gastrointestinal

Achievements

1

FDA DeNovo Granted

2

clinical studies completed

10

publications

26

families of patents filed

88

patents granted